MDBriefCase will be unavailable due to maintenance from Sunday, January 14 11PM to Monday, January 15 1AM ET.


Vaccination: Protecting Your Patients During an Ongoing Pandemic

After more than two years of life under lockdown, Canadians are eager to get back to normal and leave the pandemic behind. Healthcare professionals know better: for the foreseeable future, COVID-19 will be a part of the “new normal.”

Healthcare providers face the considerable challenge of trying to ensure patients’ safety in an ever-changing medical landscape. New variants and subvariants continue to proliferate, each seemingly more transmissible than the last. Fortunately, although vaccines are less effective at preventing any infection, they continue to be effective in preventing severe disease, hospitalization, and death.

Boosters: Who, When, and How Often?

On June 29, 2022, the National Advisory Committee on Immunization (NACI) updated its recommendations in an interim guidance statement. The Committee now strongly recommends that individuals at risk of severe illness from COVID-19 should be offered a fall booster dose, regardless of the number of booster doses previously received. Groups at risk include:

  • Older adults (at least 65 years of age)
  • Residents of long-term care facilities or congregate living settings for seniors
  • Anyone at least 12 years of age who resides in a congregate living setting
  • Anyone at least 12 years of age with an underlying medical condition that makes them at high risk of experiencing severe COVID-19
  • Adults residing in or originating from First Nations, Inuit and Métis communities
  • Adults in communities that are racialized or otherwise marginalized (for example, people with disabilities) and disproportionately affected by COVID-19

NACI also recommends that all other people between the ages of 12 and 64 may be offered a fall booster dose, regardless of the number of previous booster doses. Booster doses should be offered at six-month intervals.

Overcoming Vaccine Hesitancy

Vaccine hesitancy has been identified as a significant barrier to developing a successful COVID-19 vaccination program. Reasons for hesitancy vary. COVID 19-specific reasons include concerns about new types of vaccines, worries about harmful effects of the vaccines, favouring natural immunity, and the speed with which the vaccines were developed.

Taking Action

Healthcare professionals play a central role in overcoming vaccine hesitancy because their recommendations strongly influence vaccine acceptance by vaccine-hesitant patients. Health providers can address hesitancy by:

  • Being proactive. Instead of waiting for patients to come to you, initiate a conversation about vaccination.
  • Listening to patients. Identify your patients’ concerns so that you can deal with them.
  • Keeping things (relatively) simple. Inform and educate patients, but be careful not to overwhelm them with too much technical information.
  • Avoiding vaccine myths. Repeating myths can actually reduce patients’ intention to vaccinate.
  • Acknowledging risks. Too-strong denial can increase the perceived risks of vaccination.
  • Continuing the conversation. Take the time to help patients move from hesitancy towards acceptance, even if this requires discussing vaccination on more than one occasion.

COVID Vaccine Q&A

Below are examples of questions patients may ask about COVID-19 and suggested responses.

Q. Can mRNA vaccines alter your DNA?

A. No. The mRNA never interacts with DNA because it does not enter the nucleus (where DNA is located). The mRNA is also eliminated from your body in a few days.

Q. I’ve already had COVID-19. Do I really need to be vaccinated?

A. Yes. Being infected with COVID-19 can provide strong protection, but it’s less reliable than the protection provided by vaccination.

Q. With all the new variants, are the vaccines still effective?

A. Currently available vaccines are effective in preventing severe illness, hospitalization, and death. Booster doses are recommended to strengthen immunity and extend the period of protection.

Q. Everyone seems to be catching COVID, vaccinated or not. What’s the point of a booster?

A. The evidence suggests that less than 40 percent of Canadians aged 17 and older had been infected with the COVID-19 virus as of the end of April 2022. While COVID-19 vaccines don’t provide 100 percent protection, they do lower the risk of becoming infected. Equally important, they reduce the risk of serious illness and death.

Clinicians: Learn to identify patients who need booster doses and build confidence in discussing booster vaccination with your patients by taking this complimentary course.

Join MDBriefCase for free!

Author Agreement

In submitting your work (the “Work”) for potential posting on the MDBriefCase Healthcare Leadership Lab website (the “Website”), you (“You”) expressly agree to the following:

Review: MDBriefCase is pleased to consider the publication of Your Work on the Website.   The suitability of the Work for posting shall be determined by MDBRiefCase at its sole discretion. Nothing herein shall obligate MDBriefcase to post or otherwise publish the Work, or the maintain its posting in future.   

Editing; Identification: MDBriefcase shall have the right to edit the Work to conform to our standards of style, technological requirements, language usage, grammar and punctuation, provided that the meaning of the Work is not materially altered.  If posted, You will be identified as the author of the Work, or co-author if applicable.  

Grant of Rights:  As a condition of publication and for no monetary compensation, You hereby grant to MDBriefCase the following rights to the Work in any and all media whether now existing or hereafter developed, including print and electronic/digital formats:  (1) the exclusive right of first publication worldwide;  (2) the perpetual non-exclusive worldwide right to publish, reproduce, distribute, sell, adapt, perform, display, sublicense, and create derivative works, alone or in conjunction with other materials; (3) the perpetual non-exclusive worldwide right to use the Work, or any part thereof, in any other publication produced by MDBriefCase and/or on MDBriefCase’s website; and (4) the perpetual non-exclusive worldwide right to use the Work to promote and publicize MDBriefCase or its publications.  The grant of rights survives termination or expiration of this Agreement.    

Warranty:  You warrant that the Work is original with You and that it is not subject to any third party copyright; that You have authority to grant the rights in this Agreement; that publication of the Work will not libel anyone or infringe on or invade the rights of others; that You have full power and authority to enter into this Agreement; that the Work has not been published elsewhere in whole or in part; and that You have obtained permission from the copyright owner consistent with this Agreement for any third party copyrighted material in the Work.  This warranty survives termination or expiration of this Agreement.

Submission Agreement

Thank you for your interest in writing an article for the MDBriefCase Healthcare Leadership Lab website.

Audience and Appropriate Topics

The  Healthcare Leadership Lab welcomes submissions on all topics relevant to leaders in healthcare. Our topics include Leading in Healthcare, Leadership Lessons from COVID-19 and others. We prioritize stories that provide leadership advice to executives and managers in healthcare companies, offer actionable strategies for executing successful projects, and provide interesting angles on current healthcare topics. Submissions must be original work of the authors and unpublished.  When submitting, authors represent that they have included no material that is in violation of the rights of any other person or entity.


Articles must be educational and non-promotional. If they mention the author’s company or any of the company’s products or services by name within the text, such mention should be very limited and used for reference only, not for promotion. (For example, an author might cite a survey conducted by his company but not describe his company’s product as a solution to a business problem.) Articles will be edited for clarity, style and brevity. The final headline is determined by the editor.

Length of Submissions

Guest articles for the MDBriefCase Healthcare Leadership Lab may run between 500 and 1000 words. 


MDBriefCase reserves the right to accept or reject any submission  and the right to condition acceptance upon revision of material to conform to its criteria.   

No Compensation

There is no payment for contributed articles. However, MDBriefCase will give the author a byline. Authors are invited to link to the article on personal  websites, corporate websites and social media platforms.

Author Agreements

Each author understands and agrees that any submission accepted for posting is provided subject to MDBriefCase’s Author Agreement